TNGX: Tango Therapeutics Corp Cash Calculated per Single Share

Tango Therapeutics Corp - graphic logo of issuer TNGX

The annual trend of cash per share clearly demonstrates the solvency of Tango Therapeutics (TNGX). Business success relies on genetic research results and regulatory approvals, while the 5.75 metric indicates liquidity status. Tango Therapeutics utilizes an asset-light model with contract manufacturing, targeting the massive market for resistant oncology therapies.

Tango Therapeutics (TNGX) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for tangotx.com (TNGX)

- current quotes and average value forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:Tango Therapeutics (TNGX)
Flagship merchandise of Tango Therapeutics

This indicator is calculated as the ratio of total liquid assets to the number of shares outstanding, determining the business's actual financial strength per share. By analyzing the liquid assets per share metric, an investor assesses the ability of Tango Therapeutics (TNGX) to fund the development of targeted therapies and genetic screening within its oncology ecosystem without the risk of unused resources depreciating.